Company Filing History:
Years Active: 1997-2004
Title: Guoquing Liu: Innovator in Gene Therapy
Introduction
Guoquing Liu is a prominent inventor based in Vancouver, Canada. He has made significant contributions to the field of gene therapy, particularly in understanding and addressing the risks associated with atherosclerosis. His innovative work has led to the development of methods that can potentially improve patient outcomes in cardiovascular health.
Latest Patents
Guoquing Liu holds 2 patents that focus on gene therapy methods. His latest patents include a gene therapy method for reducing the risk of atherosclerosis and a method, reagent, and kit for evaluating susceptibility to premature coronary artery disease. The latter patent details a specific point mutation in the human lipoprotein lipase gene, which is associated with increased susceptibility to coronary artery disease, particularly premature atherosclerosis. This mutation results in diminished catalytic activity of lipoprotein lipase, lower HDL-cholesterol levels, and higher triglyceride levels, providing a basis for evaluating an individual's risk for these conditions.
Career Highlights
Guoquing Liu has established himself as a leading figure in his field through his research and innovative approaches. His work at The University of British Columbia has allowed him to explore critical aspects of gene therapy and its applications in treating cardiovascular diseases. His research has garnered attention for its potential to change the landscape of gene therapy.
Collaborations
Guoquing Liu has collaborated with notable colleagues, including Michael R. Hayden and Yuanhong Ma. These collaborations have further enriched his research and contributed to advancements in the understanding of gene therapy.
Conclusion
Guoquing Liu's contributions to gene therapy and cardiovascular health are noteworthy. His innovative patents and research efforts continue to pave the way for advancements in medical science. His work exemplifies the impact that dedicated inventors can have on improving health outcomes for individuals at risk of coronary artery disease.